Publication Name	World Journal of Clinical Cases
Manuscript ID	69640
Country	China

Category	Respiratory System
Manuscript Type	Retrospective Study
Article Title	Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections
Manuscript Source	Unsolicited Manuscript
All Author List	Wei Wu, Min Liu, Jiajing Geng and Mei Wang
Funding Agency and Grant Number
Corresponding Author	Mei Wang, MHSc, Attending Doctor, Laboratory Medicine, Bejing Tongren Hosptial, Capital Medical University, No. 2 West Ring South Road, Beijing 100176, China. wmeimeiw@163.com
Key Words	Vancomycin; Teicoplanin; Methicillin-resistant Staphylococcus aureus; Methicillin-resistant Staphylococcus epidermidis; Lung infection
Core Tip	Vancomycin and teicoplanin are both essential drugs in the clinical treatment of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis lung infections and have significant antimicrobial effects on Gram-positive cocci. Here, we discuss the efficacy and safety of these two key antibiotics.
Citation	Wu W, Liu M, Geng JJ, Wang M. Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections. World J Clin Cases 2021; 9(34): 10549-10556

Received	2021-07-28 10:12
Peer-Review Started	2021-07-28 10:13
To Make the First Decision
Return for Revision	2021-08-19 05:58
Revised	2021-08-24 13:39
Second Decision	2021-10-12 08:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-10-14 02:30
Articles in Press	2021-10-14 02:30
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-10-08 22:35
Typeset the Manuscript	2021-11-24 01:30

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com